Rapid- or short-acting insulin: ideal for preventing blood sugar spikes after meals. They begin to work much faster than long- or intermediate-acting insulins but for a shorter period of time, usually about two to four hours. Without an adequate supply of insulin to promote absorption of glu...
J. Insulin glargine. Drugs 63, 1743–1778 (2003). Article CAS PubMed Google Scholar Jonassen, I. et al. Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin. Pharm. Res. 29, 2104–2114 (2012). Article CAS PubMed PubMed Central Google ...
Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus. Domest Anim Endocrinol. 2018;65:80–9. Article CAS PubMed Google Scholar Kramer AL, et al. Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-...
17.3.5 risk documentation and communication it might be advantageous to both short- and long-acting agent insulin glargine has the advantage of strong and essentially rosis. They form a granulomatous structure around the but preventing the activa- tion of specific antipyretics, or gi toxicity from...
of all hypoglycemia between children treated with insulin glargine and NPH insulin.;Secondary Objective: Los objetivos secundarios son comparar la insulina glargina y la insulina NPH en términos de:-Índices de los tipos específicos de hipoglucemias: sintomática, severa, nocturna, nocturna...
field of medicine, but this role is still only in its infancy. This article overviews some of the key characteristics of protein therapeutics, summarizes the more than 130 protein therapeutics used currently and suggests a new classification of these proteins according to their pharmacological action....
Since the excessive classifications and the small sample size of each classification, EEs type was divided into CUA-related and CUA-unrelated to facilitate the analysis. Model Choice describes different analysis model in EEs studies. Funding means whether the identified EEs were funded by government,...
long-acting formulations such as insulin glargine (Lantus), a modified human insulin with pH-dependent solubility that forms microprecipitates in the subcutaneous space, and degludec (Tresiba), an acylated insulin analogue that forms high-molecular-weight complexes, were made possible via rational modif...
Proteins and peptides have a great potential as therapeutic agents; they have higher efficiency and lower toxicity, compared to chemical drugs. However, th